Please note that these resources are regularly reviewed to ensure that links still work correctly and that the resources listed continue to be helpful to our visitors. If you find that a link isn't working or information is incorrect, please email infocenter@lls.org. If you would like for us to consider adding your organization to this resource, please complete and submit this form.
Histiocytic Disorders are a group of rare disorders in which too many immature histiocytes (a type of immune cell) build up in certain tissues and organs, including the skin, bones, spleen, liver, lungs and lymph nodes. They can damage tissue or form an abnormal mass (called a lesion or tumor). Some histiocytic disorders are considered cancer, while others are not.
ECD Global Alliance
Population Served:
Patients, family members, and caregivers affected by Erdheim-Chester Disease, health professionals, worldwide
Dedicated to awareness, support, education, and research related to Erdheim-Chester Disease, a rare multi-system histiocytic syndrome.
- Provides disease and clinical trial information, publications, referrals to physicians and care centers, patient registry, educational events, online supports
- Funds research exploring the diagnosis, cause, treatments, and cure of Erdheim-Chester Disease
- Advocates on behalf of Erdheim-Chester Disease patients
INTO-HLH: Hemophagocytic Lymphohistiocytosis Disease Registry
Population Served:
Patients, family members, and caregivers affected by Hemophagocytic Lymphohistiocytosis and health professionals
INTO-HLH (Insight into the Natural History and Treatment Outcomes of Hemophagocytic Lymphohistiocytosis) is a disease registry aimed at advancing what is known about HLH. The insights obtained from this registry will help doctors to better diagnose and manage HLH and improve treatment outcomes for future patients.
- INTO-HLH Registry is a collaboration between Cincinnati Children's Hospital Medical Center (CCHMC), Texas Children's Hospital (TCH), and Sobi North America as the industry sponsor.
- The registry is open to all forms of HLH: Primary; Secondary (Macrophage Activation Syndrome, Cytokine Release Syndrome, Malignancy-Associated HLH).